I agree that this site is using cookies. You can find further informations here.
X
Gever, Joel R.
72  results:
Search for persons X
?
1

Fingerprinting heterocellular β-adrenoceptor functional exp..:

Matt, Rachel A. ; Westhorpe, Frederick G. ; Romuar, Rosemary F....
Frontiers in Molecular Biosciences.  10 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

The discovery and development of gefapixant:

Ford, Anthony P. ; Dillon, Michael P. ; Kitt, Michael M..
Autonomic Neuroscience.  235 (2021)  - p. 102859 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Action of MK‐7264 (gefapixant) at human P2X3 and P2X2/3 rec..:

Richards, David ; Gever, Joel R. ; Ford, Anthony P..
British Journal of Pharmacology.  176 (2019)  13 - p. 2279-2291 , 2019
Link: https://doi.org/10.1111/..
 
?
4

Novel compounds lowering the cellular isoform of the human ..:

Silber, B. Michael ; Gever, Joel R. ; Rao, Satish...
Bioorganic & Medicinal Chemistry.  22 (2014)  6 - p. 1960-1972 , 2014
Link: https://doi.org/10.1016/..
 
?
5

Towards Optimization of Arylamides As Novel, Potent, and Br..:

Li, Zhe ; Rao, Satish ; Gever, Joel R....
ACS Medicinal Chemistry Letters.  4 (2013)  7 - p. 647-650 , 2013
Link: https://doi.org/10.1021/..
 
?
6

Discovery and Preliminary Structure–Activity Relationship o..:

Li, Zhe ; Gever, Joel R. ; Rao, Satish...
ACS Medicinal Chemistry Letters.  4 (2013)  4 - p. 397-401 , 2013
Link: https://doi.org/10.1021/..
 
?
7

Pharmacokinetics and Metabolism of 2-Aminothiazoles with An..:

Silber, B. Michael ; Rao, Satish ; Fife, Kimberly L....
Pharmaceutical Research.  30 (2013)  4 - p. 932-950 , 2013
Link: https://doi.org/10.1007/..
 
?
8

Antiprion compounds that reduce PrPSc levels in dividing an..:

Silber, B. Michael ; Gever, Joel R. ; Li, Zhe...
Bioorganic & Medicinal Chemistry.  21 (2013)  24 - p. 7999-8012 , 2013
Link: https://doi.org/10.1016/..
 
?
9

2‐Aminothiazoles with Improved Pharmacotherapeutic Properti..:

Li, Zhe ; Silber, B. Michael ; Rao, Satish...
ChemMedChem.  8 (2013)  5 - p. 847-857 , 2013
Link: https://doi.org/10.1002/..
 
?
10

Discovery and optimization of RO-85, a novel drug-like, pot..:

Brotherton-Pleiss, Christine E. ; Dillon, Michael P. ; Ford, Anthony P.D.W....
Bioorganic & Medicinal Chemistry Letters.  20 (2010)  3 - p. 1031-1036 , 2010
Link: https://doi.org/10.1016/..
 
?
11

AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3..:

Gever, Joel R ; Soto, Rothschild ; Henningsen, Robert A...
British Journal of Pharmacology.  160 (2010)  6 - p. 1387-1398 , 2010
Link: https://doi.org/10.1111/..
 
?
12

Identification and SAR of novel diaminopyrimidines. Part 1:..:

Carter, David S. ; Alam, Muzaffar ; Cai, Haiying...
Bioorganic & Medicinal Chemistry Letters.  19 (2009)  6 - p. 1628-1631 , 2009
Link: https://doi.org/10.1016/..
 
?
13

Identification and SAR of novel diaminopyrimidines. Part 2:..:

Jahangir, Alam ; Alam, Muzaffar ; Carter, David S....
Bioorganic & Medicinal Chemistry Letters.  19 (2009)  6 - p. 1632-1635 , 2009
Link: https://doi.org/10.1016/..
 
?
14

Thermodynamic analysis of P2X7 purinoceptor ligand binding:

Martin, Renee S ; Weber, Patrick ; Apparsundaram, Subbu...
The FASEB Journal.  22 (2008)  S2 - p. 627-627 , 2008
Link: https://doi.org/10.1096/..
 
?
15

Pharmacology of P2X channels:

Gever, Joel R. ; Cockayne, Debra A. ; Dillon, Michael P...
Pflügers Archiv - European Journal of Physiology.  452 (2006)  5 - p. 513-537 , 2006
Link: https://doi.org/10.1007/..
 
1-15